Edition:
United Kingdom

NewLink Genetics Corp (NLNK.OQ)

NLNK.OQ on NASDAQ Stock Exchange Global Market

1.66USD
20 May 2019
Change (% chg)

-- (--)
Prev Close
$1.66
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
101,789
52-wk High
$5.60
52-wk Low
$1.28

About

NewLink Genetics Corporation is a clinical-stage immuno-oncology company focused on discovering, developing and commercializing immunotherapeutic products for the treatment of cancer. The Company's portfolio includes biologic and small-molecule immunotherapy product candidates for a range of oncology indications. Its biologic... (more)

Overall

Beta: 1.77
Market Cap(Mil.): $61.88
Shares Outstanding(Mil.): 37.28
Dividend: --
Yield (%): --

Financials

  NLNK.OQ Industry Sector
P/E (TTM): -- 101.85 55.51
EPS (TTM): -1.22 -- --
ROI: -34.15 7.41 11.59
ROE: -37.00 7.88 16.33

Earnings vs. Estimates